How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

IAM1363-01: A Phase 1/1b Study of a Selective and Brain-Penetrant HER2 Inhibitor for HER2-Driven Solid Tumors

calendar_today June 1, 2024 person domain iambic

Clinical trial findings presented at a major oncology conference for a novel cancer therapeutic.

open_in_new Read original post